Published in Gut on January 31, 2011
Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis. PLoS One (2014) 1.44
Cancer odor in the blood of ovarian cancer patients: a retrospective study of detection by dogs during treatment, 3 and 6 months afterward. BMC Cancer (2013) 1.19
The therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancer. Antioxid Redox Signal (2014) 1.17
Using a dog's superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study. BMJ (2012) 1.08
Context specificity of inhibitory control in dogs. Anim Cogn (2013) 0.98
Exhaled breath analysis for lung cancer. J Thorac Dis (2013) 0.96
More than apples and oranges--detecting cancer with a fruit fly's antenna. Sci Rep (2014) 0.87
A highly accurate inclusive cancer screening test using Caenorhabditis elegans scent detection. PLoS One (2015) 0.86
Comparative analysis of volatile metabolomics signals from melanoma and benign skin: a pilot study. Metabolomics (2013) 0.84
Electronic nose versus canine nose: clash of the titans. Gut (2011) 0.80
Real-Time Detection of a Virus Using Detection Dogs. Front Vet Sci (2016) 0.79
Targeted proteomics for multiplexed verification of markers of colorectal tumorigenesis. Mol Cell Proteomics (2017) 0.78
Canine olfactory detection of malignant melanoma. BMJ Case Rep (2013) 0.77
Point-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directions. World J Gastroenterol (2015) 0.77
Familial colorectal cancer screening: When and what to do? World J Gastroenterol (2015) 0.77
Breath testing: the future for digestive cancer detection. Expert Rev Gastroenterol Hepatol (2013) 0.76
Diagnosing gastrointestinal illnesses using fecal headspace volatile organic compounds. World J Gastroenterol (2016) 0.76
De novo copy number variations in cloned dogs from the same nuclear donor. BMC Genomics (2013) 0.76
An odor detection system based on automatically trained mice by relative go no-go olfactory operant conditioning. Sci Rep (2015) 0.75
Canine Detection of the Volatilome: A Review of Implications for Pathogen and Disease Detection. Front Vet Sci (2016) 0.75
A non-invasive tool for detecting cervical cancer odor by trained scent dogs. BMC Cancer (2017) 0.75
Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A Review. Sensors (Basel) (2016) 0.75
Use of the Analysis of the Volatile Faecal Metabolome in Screening for Colorectal Cancer. PLoS One (2015) 0.75
Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 16.82
The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med (2000) 13.19
Hereditary colorectal cancer. N Engl J Med (2003) 11.86
Screening for colorectal cancer: recommendation and rationale. Ann Intern Med (2002) 6.56
Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med (2000) 6.26
Cost-effectiveness of screening for colorectal cancer in the general population. JAMA (2000) 5.88
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57
Clinical features of colorectal cancer before diagnosis: a population-based case-control study. Br J Cancer (2005) 4.19
Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol (2000) 4.17
Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA (1993) 3.91
Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ (2004) 3.80
Olfactory detection of human bladder cancer by dogs: proof of principle study. BMJ (2004) 3.32
Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology (2002) 3.08
Sniffer dogs in the melanoma clinic? Lancet (1989) 2.90
Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther (2006) 2.15
Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem (1985) 1.83
Volatile markers of breast cancer in the breath. Breast J (2003) 1.82
Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut (2008) 1.79
Colorectal cancer screening: clinical applications. JAMA (2003) 1.74
Breath hydrogen excretion as a screening test for the early diagnosis of necrotizing enterocolitis. Am J Dis Child (1989) 1.58
Cost effectiveness of a new strategy to identify HNPCC patients. Gut (2005) 1.38
Human ovarian carcinomas detected by specific odor. Integr Cancer Ther (2008) 1.37
Another sniffer dog for the clinic? Lancet (2001) 1.30
Analysis of lung air from patients with bronchogenic carcinoma and controls using gas chromatography-mass spectrometry. J Chromatogr (1988) 1.28
Prediction of breast cancer using volatile biomarkers in the breath. Breast Cancer Res Treat (2006) 1.26
A computerized classification technique for screening for the presence of breath biomarkers in lung cancer. Clin Chem (1988) 1.23
Cost effectiveness of colorectal cancer screening in the elderly. Ann Intern Med (1991) 1.14
Increased pentane and carbon disulfide in the breath of patients with schizophrenia. J Clin Pathol (1993) 1.12
Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance. Endoscopy (2008) 1.06
Breath tests in medicine. Sci Am (1992) 1.06
A novel breath test for the non-invasive assessment of small intestinal mucosal injury following methotrexate administration in the rat. Scand J Gastroenterol (2004) 1.05
Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model. CMAJ (2009) 1.03
Cost-effectiveness analysis of strategies for colorectal cancer screening in Japan. Int J Technol Assess Health Care (1994) 0.94
Feasible economic strategies to improve screening compliance for colorectal cancer in Korea. World J Gastroenterol (2005) 0.92
Breath alkanes determination in ulcerative colitis and Crohn's disease. Dis Colon Rectum (1999) 0.89
Method for the collection and analysis of volatile compounds in the breath. J Chromatogr (1991) 0.84
Screening for the Lynch syndrome. N Engl J Med (2005) 0.83
Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology (2006) 2.33
Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations. Blood (2007) 2.23
Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma. Ann Thorac Surg (2006) 2.21
Optimal range of global end-diastolic volume for fluid management after aneurysmal subarachnoid hemorrhage: a multicenter prospective cohort study. Crit Care Med (2014) 2.15
Obstructing spontaneous major shunt vessels is mandatory to keep adequate portal inflow in living-donor liver transplantation. Transplantation (2013) 2.14
Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib. J Thorac Oncol (2011) 2.07
Reciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer. Clin Cancer Res (2010) 2.05
Bile duct adenoma and von Meyenburg complex-like duct arising in hepatitis and cirrhosis: pathogenesis and histological characteristics. Pathol Int (2014) 2.01
Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer. Clin Cancer Res (2005) 1.99
Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int (2005) 1.96
Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer. Clin Cancer Res (2006) 1.89
Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C. Liver Int (2010) 1.86
Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol (2012) 1.84
Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers. Int J Cancer (2011) 1.81
Deregulation of the Akt pathway in human cancer. Curr Cancer Drug Targets (2008) 1.75
Giant inguinal hernia containing right colon repaired using the prolene hernia system. ANZ J Surg (2008) 1.72
Physical activity and colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Sci (2006) 1.72
Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study. Gastroenterology (2008) 1.65
Diabetic microangiopathy in ischemic limb is a disease of disturbance of the platelet-derived growth factor-BB/protein kinase C axis but not of impaired expression of angiogenic factors. Circ Res (2005) 1.64
Risk factors for and management of delayed intraperitoneal hemorrhage after pancreatic and biliary surgery. Am J Surg (2007) 1.64
Association between arterial stiffness and cerebral white matter lesions in community-dwelling elderly subjects. Hypertens Res (2008) 1.60
Conversion from the "oncogene addiction" to "drug addiction" by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation. Lung Cancer (2011) 1.60
Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. J Gastroenterol Hepatol (2008) 1.59
Reconstruction of the middle hepatic vein tributaries using the recipient's recanalized umbilical vein in right-lobe living-donor liver transplantation. Surgery (2006) 1.58
Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin Cancer Res (2004) 1.58
Activation of PI3K/Akt signaling and hormone resistance in breast cancer. Breast Cancer (2006) 1.57
Advances in esophageal cancer surgery in Japan: an analysis of 1000 consecutive patients treated at a single institute. Surgery (2008) 1.57
Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg (2013) 1.56
Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients. Int J Cancer (2006) 1.51
Risk factors that increase mortality after living donor liver transplantation. Transplantation (2012) 1.51
Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation. Transplantation (2008) 1.51
Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey. Transpl Int (2014) 1.49
Mutations in hepatitis C virus genotype 1b and the sensitivity of interferon-ribavirin therapy after liver transplantation. J Hepatol (2010) 1.48
The effects of neoadjuvant chemotherapy and chemo-radiation therapy on MRI staging in invasive bladder cancer: comparative study based on the pathological examination of whole layer bladder wall. Int Urol Nephrol (2009) 1.48
Ectopic pleural thymoma presenting as a giant mass in the thoracic cavity. Ann Thorac Surg (2007) 1.47
Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C. Gastroenterology (2010) 1.47
Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer. Oncogene (2003) 1.47
The changes of the medial right lobe, transplanted with left lobe liver graft from living donors. Transplantation (2009) 1.42
Sprouty2 and Sprouty4 are essential for embryonic morphogenesis and regulation of FGF signaling. Biochem Biophys Res Commun (2006) 1.41
Alternative efficacy-predicting markers for paclitaxel instead of CHFR in non-small-cell lung cancer. Cancer Biol Ther (2010) 1.41
Trends in the incidence and survival of intracerebral hemorrhage by its location in a Japanese community. Circ J (2013) 1.41
Successful prolonged rituximab treatment for post-transplant lymphoproliferative disorder following living donor liver transplantation in a child. Pediatr Transplant (2007) 1.40
Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer. Int J Cancer (2005) 1.39
Selection of a right posterior sector graft for living donor liver transplantation. Liver Transpl (2014) 1.38
Is an elderly recipient a risk for living donor adult liver transplantation? Hepatogastroenterology (2008) 1.38
Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients. J Am Coll Surg (2007) 1.37
Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling. Mol Cell Biol (2007) 1.34
Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study. Obesity (Silver Spring) (2007) 1.34
Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma. Oncology (2007) 1.33
Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significance. Lung Cancer (2005) 1.32
Acquired resistance mechanisms to tyrosine kinase inhibitors in lung cancer with activating epidermal growth factor receptor mutation--diversity, ductility, and destiny. Cancer Metastasis Rev (2012) 1.32
Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet (2012) 1.32
Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. Int J Clin Oncol (2010) 1.31
The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol (2007) 1.30
Trastuzumab and breast cancer: developments and current status. Int J Clin Oncol (2006) 1.30
Concurrent genetic alterations in DNA polymerase proofreading and mismatch repair in human colorectal cancer. Eur J Hum Genet (2010) 1.30
The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study. Am J Epidemiol (2006) 1.29
Platelet-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas. Cancer Res (2005) 1.29
Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection. Hepatogastroenterology (2003) 1.29
Living donor liver transplantation in a patient with giant hepatic hemangioma complicated by Kasabach-Merritt syndrome: report of a case. Surg Today (2008) 1.28
Successful management of chylous ascites after living donor liver transplantation with somatostatin. Liver Int (2008) 1.28
Phase 2 study of nilotinib as third-line therapy for patients with gastrointestinal stromal tumor. Cancer (2011) 1.27
Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B. Nat Commun (2012) 1.27
Gastric metastasis from lung carcinoma. Case report. Hepatogastroenterology (2002) 1.24
Essential role of PDGFRalpha-p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFRalpha during angiogenesis. Circ Res (2004) 1.23
Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surg Today (2011) 1.23
Risk factors associated with surgical site infection in upper and lower gastrointestinal surgery. Surg Today (2008) 1.22
Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma. Clin Cancer Res (2003) 1.21
Never-smoking nonsmall cell lung cancer as a separate entity: clinicopathologic features and survival. Cancer (2008) 1.20
Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma. Mod Pathol (2008) 1.19
The efficacy of balloon-occluded retrograde transvenous obliteration on small intestinal variceal bleeding. Surgery (2009) 1.19
Construct validity for eye-hand coordination skill on a virtual reality laparoscopic surgical simulator. Surg Endosc (2007) 1.19
Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1*28 and/or UGT1A1*6 polymorphisms. Cancer Sci (2011) 1.17
Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int J Clin Oncol (2010) 1.17
The association between Akt activation and resistance to hormone therapy in metastatic breast cancer. Eur J Cancer (2006) 1.16
Immunohistochemical expression of C-reactive protein in squamous cell carcinoma of the esophagus - significance as a tumor marker. Cancer Lett (2003) 1.16
No hypersensitive estrogen receptor-alpha mutation (K303R) in Japanese breast carcinomas. Breast Cancer Res Treat (2004) 1.16
Gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor. Gastric Cancer (2005) 1.15
Clinicopathologic significance of hypoxia-inducible factor 1alpha overexpression in gastric carcinomas. J Surg Oncol (2006) 1.15